Goodyear approves EMEA rationalization plan; net reduction of ~400 positions, $100M-$110M pre-tax charges

This filing

the rationalization plan remain subject to consultation with employee representative bodies. The total pre-tax charges associated with these actions are expected to be between $100 million and $110 million, of which $75 million to $85 million are expected to be rationalization charges primarily for associate-related and other exit costs. Total cash outflows for

Comparable filing

On June 1, 2026, Manhattan Associates, Inc. (“Manhattan”) initiated plans to reduce its global headcount by approximately 6%, leveraging increased operational efficiencies and allowing it to focus investments on key strategic priorities. Manhattan estimates that it will incur expenses, substantially all in cash, of approximately $7 million to $9 million in the second quarter of 2026, consisting of severance and other one-time termination benefits in connection with these actions.

This filing

the rationalization plan remain subject to consultation with employee representative bodies. The total pre-tax charges associated with these actions are expected to be between $100 million and $110 million, of which $75 million to $85 million are expected to be rationalization charges primarily for associate-related and other exit costs. Total cash outflows for

Comparable filing

Plan as well as savings related to certain restricted stock units lapsing over the next twelve months. The Company estimates that it will incur pre-tax charges in the range of $0.14 million to $0.20 million in connection with the Plan, consisting of approximately $0.10 to $0.15 in future cash-based expenditures associated with severance and benefit payments and

This filing

the rationalization plan remain subject to consultation with employee representative bodies. The total pre-tax charges associated with these actions are expected to be between $100 million and $110 million, of which $75 million to $85 million are expected to be rationalization charges primarily for associate-related and other exit costs. Total cash outflows for

Comparable filing

underlying real property but has not entered into a contract of sale as of the date of this report. The Company expects to incur pre-tax non-recurring charges of approximately $43 million under the plan, of which approximately $36 million is expected to consist of impairment charges relating to fixed asset and inventory write-downs and approximately $7 million is

This filing

the rationalization plan remain subject to consultation with employee representative bodies. The total pre-tax charges associated with these actions are expected to be between $100 million and $110 million, of which $75 million to $85 million are expected to be rationalization charges primarily for associate-related and other exit costs. Total cash outflows for

Comparable filing

The Plan involves a reduction of the Company’s workforce by approximately 700 employees, representing approximately 14% of the Company’s global workforce as of May 1, 2026. The Company expects execution of the Plan to be substantially complete in the second quarter of 2026. In connection with these actions, the Company estimates that it will incur approximately $50 million to $60 million in total restructuring expenses

This filing

the rationalization plan remain subject to consultation with employee representative bodies. The total pre-tax charges associated with these actions are expected to be between $100 million and $110 million, of which $75 million to $85 million are expected to be rationalization charges primarily for associate-related and other exit costs. Total cash outflows for

Comparable filing

Item 2.05 Costs Associated with Exit or Disposal Activities. On April 29, 2026, Autolus Therapeutics plc (the “Company”) announced its Board of Directors approved a plan to improve operational efficiency and reduce operating expenses. This plan will implement a reduction in force whereby the Company will eliminate approximately 13% of the Company’s workforce, inclusive of employee-related actions that began in the second half of 2025. The Company anticipates that it will complete the implementation of the plan by the third quarter of 2026. Affected employees will be offered separation benefits, including severance payments and, where applicable, temporary healthcare coverage assistance. The Company estimates that it will incur total expenses relating to the realignment of approximately $8 million, consisting of severance and termination-related costs. The Company expects to record a significant portion of these charges in the first half of 2026.

This filing

the rationalization plan remain subject to consultation with employee representative bodies. The total pre-tax charges associated with these actions are expected to be between $100 million and $110 million, of which $75 million to $85 million are expected to be rationalization charges primarily for associate-related and other exit costs. Total cash outflows for

Comparable filing

On April 28, 2026, the Vertex, Inc. (the “Company”) announced its Board of Directors (the “Board”) approved a global Value Creation Plan (the “Plan”) intended to become a more AI-enabled company, focus investments on key growth opportunities and drive operational efficiency to better align the Company’s workforce and resources with its long-term strategic priorities. The Plan includes a reduction in force of approximately 170 employees, representing approximately 9% of the Company’s global workforce as of April 27, 2026. In connection with the Plan, the Company estimates that it will incur aggregate pre-tax charges of approximately $6 million to $8 million, consisting primarily of cash expenditures related to employee severance, notice pay, statutory termination indemnities, and other employee separation benefits.

This filing

the rationalization plan remain subject to consultation with employee representative bodies. The total pre-tax charges associated with these actions are expected to be between $100 million and $110 million, of which $75 million to $85 million are expected to be rationalization charges primarily for associate-related and other exit costs. Total cash outflows for

Comparable filing

the Company approved a plan to reduce its workforce, currently affecting 64 employees, a 40% reduction in workforce as compared to December 31, 2025.

This filing

the rationalization plan remain subject to consultation with employee representative bodies. The total pre-tax charges associated with these actions are expected to be between $100 million and $110 million, of which $75 million to $85 million are expected to be rationalization charges primarily for associate-related and other exit costs. Total cash outflows for

Comparable filing

On April 9, 2026, the Company also announced a cost reduction program that includes a reduction in the Company’s workforce of approximately 11% of its full-time roles, including certain management roles and two executive roles. In connection with this workforce reduction, the Company expects to incur aggregate charges of approximately $8.5-$9 million, consisting primarily of employee-related costs, including severance, benefits, and other related expenses.